Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.

about

Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q55040229

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@en

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@nl

type

Item

label

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@en

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@nl

prefLabel

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@en

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@nl

P1476

Pharmacokinetics of continuous ...... nced hepatocellular carcinoma.

@en

P2093

Hai Liao

http://www.w3.org/2001/XMLSchema#string

Jian Gao

http://www.w3.org/2001/XMLSchema#string

Rui Zhen

http://www.w3.org/2001/XMLSchema#string

Wenbo Guo

http://www.w3.org/2001/XMLSchema#string

Wenquan Zhuang

http://www.w3.org/2001/XMLSchema#string

P2860

Current Status of Hepatic Arterial Infusion Chemotherapy

Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma

Catheter replacement of the needle in percutaneous arteriography; a new technique

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy

Management of hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin.

P304

7175-7181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8242

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29725440

http://www.w3.org/2001/XMLSchema#string

P932

5920382

http://www.w3.org/2001/XMLSchema#string